IceCure Medical Ltd. ICCM shares are soaring Wednesday after the company reported a 70% jump in its U.S. commercial install ...

CAESAREA, Israel, Jan. 27, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...

IceCure reported a 70% increase in its active U.S. commercial install base of ProSense systems.

CAESAREA, Israel, Dec. 13, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as ...

CAESAREA, Israel, Oct. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted marketing authorization for ProSense®, a minimally invasive cryoablation treatment for patients ...

Purchase funded by the Thomas Foundation following FDA marketing authorization of ProSense(R) in low-risk breast cancer and inclusion of cryoablation in proposed medical society guidelines CAESAREA, ...

CAESAREA, Israel, May 31, 2023 /PRNewswire/ -- IceCure Medical Ltd. (ICCM) (Nasdaq: ICCM) (TASE: ICCM) developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys ...

At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated 89.4% recurrence-free rate in patients with tumors ≤3 cm and 83.9% of patients remained ...

IceCure Medical Ltd. (NASDAQ:ICCM), the developer of minimally invasive cryoablation technology that destroys tumors by freezing them, was granted marketing authorization from the U.S. Food and Drug ...

One of the biggest frustrations with GPS running watches has always been battery life. These devices are great for recording workout data, but with satellite tracking turned on they can run out of ...